Idioma:

GW27-e0551 Enhancement of anticoagulant action due to warfarin and benzbromarone co-prescription in patients with atrial fibrillation accompanying gout

Qu, Caihong ; Li, Xiaoyan ; Zhu, Jieming ; Tao, Ling

Journal of the American College of Cardiology, 2016-10, Vol.68 (16), p.C75-C75 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
GW27-e0551 Enhancement of anticoagulant action due to warfarin and benzbromarone co-prescription in patients with atrial fibrillation accompanying gout
Autor: Qu, Caihong ; Li, Xiaoyan ; Zhu, Jieming ; Tao, Ling
Assuntos: Anticoagulants ; Cardiac arrhythmia ; Cardiology ; Cardiovascular ; Internal Medicine
É parte de: Journal of the American College of Cardiology, 2016-10, Vol.68 (16), p.C75-C75
Descrição: Objectives Benzbromarone is an inhibitor of CYP2C9 and it may be involved in drug interactions with warfarin dependent on this enzyme for clearance, especially in patients with atrial fibrillation accompanying gout needing warfarin and benzbromarone co-prescription.
Editor: New York: Elsevier Inc
Idioma: Inglês

Voltar para lista de resultados